For the very first time, a study led by Julian Chen and his group in Arizona State University’s School of Molecular Sciences and the Biodesign Institute’s Center for the Mechanism of Evolution, has ...

When our health care workers start receiving their coronavirus vaccines this week, it will appear as if they’re getting any other shot in their upper arm. But the technology used to develop the Pfizer ...

A commonly used strategy in the development of messenger RNA (mRNA) medicine is based on the destruction of disease-causing mRNA. Achieving the opposite and stabilizing health-promoting mRNA is still ...

Please provide your email address to receive an email when new articles are posted on . Participants who received two doses of a messenger RNA COVID-19 vaccine were 80% less likely to test positive ...

Intracellular machines called ribosomes use messenger-RNA sequences to synthesize proteins. Investigations using single-molecule imaging and cryo-electron microscopy techniques reveal structural and ...

The huge push for a vaccine based on messenger RNA (mRNA) against Covid-19 is beginning to bear fruit, and promises to be a revolution in the fight against infectious diseases. What does the work with ...

If the Pfizer and Moderna vaccines successfully put an end to the COVID-19 pandemic, as they seem poised to do, we will owe our salvation to the development of mRNA vaccines — an unprecedented, novel ...

Engineers at MIT and the University of Massachusetts Medical School have designed a new type of nanoparticle that can be administered to the lungs, where it can deliver messenger RNA encoding useful ...

Exsilio Therapeutics launched on Wednesday with an $82 million series A fundraising round co-led by Novartis Venture Fund and Delos Capital. The company’s interim CEO, Tal Zaks, says that while ...

PARIS (AP) — French drugmaker Sanofi said Tuesday it was shelving plans for a COVID-19 vaccine based on messenger RNA despite positive results from early stage testing. The Paris-based company said it ...